Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease

por Dörr, Katharina, Kainz, Alexander, Oberbauer, Rainer
Publicado 2022

Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis—a post-hoc analysis of a randomized...

por Dörr, Katharina, Kammerlander, Andreas, Lauriero, Francesco, Lorenz, Matthias, Marculescu, Rodrig, Beitzke, Dietrich
Publicado 2023

Etelcalcetide Inhibits the Progression of Left Atrial Volume Index Compared to Alfacalcidol in Hemodialysis Patients

por Dörr, Katharina, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Marculescu, Rodrig, Beitzke, Dietrich, Hödlmoser, Sebastian
Publicado 2023

Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)

por Dörr, Katharina, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Loewe, Christian, Marculescu, Rodrig, Erben, Reinhold, Oberbauer, Rainer
Publicado 2019

The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis

por Dörr, Katharina, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Marculescu, Rodrig, Poglitsch, Marko, Beitzke, Dietrich, Oberbauer, Rainer
Publicado 2022

Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is...

por Dörr, Katharina, Hödlmoser, Sebastian, Kammer, Michael, Reindl-Schwaighofer, Roman, Lorenz, Matthias, Reiskopf, Bianca, Jagoditsch, Rahel, Marculescu, Rodrig, Oberbauer, Rainer
Publicado 2022